Boehringer Ingelheim launches contract manufacturing brand

Boehringer Ingelheim has set up a new dedicated brand identity for its successful and growing biopharmaceutical contract manufacturing business.

The Boehringer Ingelheim BioXcellence brand will unify the organisation's manufacturing functions and expertise, with a new website having been launched to showcase its services and capabilities.

Since entering this field more than 35 years ago, the company has helped to bring 19 customer products to market, with its dedication to quality reflected in its new corporate mission statement, 'Producing Value'.

The brand is being officially launched at the BIO US industry conference in Boston this week.

Simon Sturge, senior vice-president for biopharmaceuticals at Boehringer Ingelheim, said: "Our new brand … will help our customers and the market identify with the quality and reliability which has made Boehringer Ingelheim's biopharmaceutical contract manufacturing business one of the largest in the world."

Earlier this week, the company was presented with an award from the Hertie Foundation in recognition of its commitment to family-friendly management and working practices.